StockNews.com Begins Coverage on Aptose Biosciences (NASDAQ:APTO)
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a report issued on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Other analysts also recently issued reports about the company. Canaccord Genuity Group cut their price objective on Aptose Biosciences from $15.00 to $6.00 and […]
More Stories
Bentley Systems, Incorporated (NASDAQ:BSY) Receives $59.57 Average PT from Analysts
Shares of Bentley Systems, Incorporated (NASDAQ:BSY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from...
Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) Given Average Rating of “Moderate Buy” by Brokerages
Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI – Get Free Report) has received an average recommendation of “Moderate Buy” from the...
Occidental Petroleum (NYSE:OXY) PT Lowered to $65.00
Occidental Petroleum (NYSE:OXY – Get Free Report) had its price target decreased by investment analysts at BMO Capital Markets from...
Calix’s (CALX) Buy Rating Reiterated at Rosenblatt Securities
Rosenblatt Securities restated their buy rating on shares of Calix (NYSE:CALX – Free Report) in a research report sent to...
BlackRock (NYSE:BLK) Given New $1,040.00 Price Target at The Goldman Sachs Group
BlackRock (NYSE:BLK – Free Report) had its price objective increased by The Goldman Sachs Group from $960.00 to $1,040.00 in...
JPMorgan Chase & Co. Lowers ChargePoint (NYSE:CHPT) to Underweight
JPMorgan Chase & Co. downgraded shares of ChargePoint (NYSE:CHPT – Free Report) from an overweight rating to an underweight rating...